Relevant bibliographies by topics / Lactation – Drug effects / Books
To see the other types of publications on this topic, follow the link: Lactation – Drug effects.

Books on the topic 'Lactation – Drug effects'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 40 books for your research on the topic 'Lactation – Drug effects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Briggs, Gerald G. Drugs in lactation. 2nd ed. Baltimore: Williams & Wilkins, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1935-, Freeman Roger K., and Yaffe Sumner J. 1923-, eds. Drugs in Pregnancy and Lactation. 7th ed. Baltimore: Lippincott Williams & Wilkins, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Program, Motherisk, ed. Cancer in pregnancy and lactation: The Motherisk guide. Cambridge, UK: Cambridge University Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Briggs, Gerald G. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 3rd ed. Baltimore: Williams & Wilkins, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1935-, Freeman Roger K., and Yaffe Sumner J. 1923-, eds. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

G, Briggs Gerald, Nageotte Michael P, and American Society of Health-System Pharmacists., eds. Diseases, complications, and drug therapy in obstetrics: A guide for clinicians. Bethesda, Md: American Society of Health-System Pharmacists, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Briggs, Gerald G. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk on CD-ROM. [Philadelphia, Pa.]: Lippincott, Williams & Wilkins, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hale, Thomas Wright. Medications and mothers' milk. Amarillo, TX: Pharmasoft Medical Pub., 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hale, Thomas Wright. Medications and mothers' milk. Amarillo, TX: Pharmasoft Medical Publishing, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Medications and mothers' milk. 4th ed. Amarillo, Tex: Pharmasoft Medical Publishing, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

C, Petersen Robert, Moore Dorothy Tuell, Haase Tineke Boddé, and United States. Alcohol, Drug Abuse, and Mental Health Administration. Office for Substance Abuse Prevention., eds. Alcohol, tobacco, and other drugs may harm the unborn. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Office for Substance Abuse Prevention, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Cook, Paddy Shannon. Alcohol, tobacco, and other drugs may harm the unborn. Rockville, MD (Rockwall II, 5600 Fishers Lane, Rockville 20857): U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Office for Substance Abuse Prevention, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Cook, Paddy Shannon. Alcohol, tobacco, and other drugs may harm the unborn. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Office for Substance Abuse Prevention, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Cook, Paddy Shannon. Alcohol, tobacco, and other drugs may harm the unborn. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Office for Substance Abuse Prevention, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Weiner, Carl P. Drugs for pregnant and lactating women. New York: Churchill Livingstone, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Catalin, Buhimschi, ed. Drugs for pregnant and lactating women. 2nd ed. Philadelphia: Saunders/Elsevier, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Drugs in Pregnancy and Lactation. Lippincott Williams & Wilkins, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

1963-, Lee Anne, Inch Sally 1951-, and Finnigan David, eds. Therapeutics in pregnancy and lactation. Abingdon, Oxon: Radcliffe Medical Press, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Lee, Anne. Therapeutics in Pregnancy And Lactation. Radcliffe Medical Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kraemer, Oliver, and Timothée Fraisse. Drugs in pregnancy and lactation. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198713333.003.0011.

Full text
Abstract:
Medical or surgical interventions, requiring anaesthesia and/or analgesia, are frequent during various stages of pregnancy and lactation when the mother, the embryo/fetus, and the breastfeeding infant are vulnerable. Many physiological alterations occur during pregnancy, which might result in modified pharmacokinetic/pharmacodynamic drug profiles. These are often challenging situations for the treating physician who has to rely on scarce clinical or epidemiological data to support their prescriptions. This chapter reviews the underlying principles of pharmacology and related toxicity during pregnancy and lactation. It outlines current recommendations for most commonly used drugs in anaesthesia (i.e. local anaesthetics, hypnotics, opioids, and muscle relaxants) and pain relief (i.e. analgesics and anti-inflammatory drugs). It should not be considered as an exhaustive description of the potential side effects nor should it be used as a prescription guide for specific clinical situations. When administering drugs to pregnant or lactating women, one should always refer to up-to-date best standard of care and review references, which should be clearly documented in the patient’s medical record, especially with respect to newly marketed compounds.
APA, Harvard, Vancouver, ISO, and other styles
21

A, Berrebi, ed. Guide des médicaments anti-infectieux lors de la grossesse et de l'allaitement. Rueil-Malmaison: Doin, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Christof, Schaefer, Peters P. W. J, and Miller Richard K. 1946-, eds. Drugs during pregnancy and lactation: Treatment options and risk assessment. 2nd ed. Amsterdam: Elsevier Academic Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Miller, Richard K., Christof Schaefer, and Paul W. J. Peters. Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment. Elsevier Science & Technology Books, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 7th ed. Lippincott Williams & Wilkins, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

N, Bennett P., and World Health Organization. Regional Office for Europe., eds. Drugs and human lactation: A guide to the content and consequences of drugs, micronutrients, radiopharmaceuticals, and environmental and occupational chemicals in human milk. Amsterdam: Elsevier, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Hale, Thomas Wright. Medications and mothers' milk. 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

N, Bennett P., and Jensen Allan A, eds. Drugs and human lactation: A comprehensive guide to the content and consequences of drugs, micronutrients, radiopharmaceuticals, and environmental and occupational chemicals in human milk. 2nd ed. Amsterdam: Elsevier, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Medications & Mothers' Milk: 2019. Springer Publishing Company, Incorporated, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Ainsworth, Sean. Neonatal Formulary. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198840787.001.0001.

Full text
Abstract:
Neonatal Formulary bridges a gap between a standard formulary (stating doses, indications, etc.) and a standard neonatal textbook by expanding information about the conditions for which each drug is used. Much of drug use during pregnancy, lactation, and in neonates and young infants is ‘off license’ (i.e. using licensed drugs but for an indication that is outside the licensed use—in many cases simply because the studies and the licensing application did not include data about neonatal use). The book offers information to allow practitioners to make informed choices whether to use such a drug or not by presenting data from published studies to support such a use. Part 1 concentrates on drug prescribing and drug administration, presenting general information on drug storage, drug licensing, and drug prescribing. It also explains to the reader why the metabolism of drugs differs in premature and sick infants and why the practice of extrapolating doses from adult studies is wrong. Patient safety, excipients, and therapies that affect drug metabolism (such as therapeutic hypothermia) are also covered. Part 2 consists of drug monographs for over 250 drugs that may find use in the neonatal population but which nonetheless may also find use outside the neonatal unit. Each monograph is divided into sections covering use, pharmacology, treatment, drug interactions, or other administration information, supply, and administration, and references. The monographs also contain links to Cochrane Database of Systematic Reviews and national guidelines supported by bodies such as the National Institute for Health and Care Excellence or the Royal Colleges. Part 3 contains brief notes on a range of additional drugs and groups of drugs that are often taken by mothers during pregnancy, labour, or during breast feeding where effects on either the fetus or infant can be seen. This information will help to provide safe and effective prescribing of drugs to all mothers and their babies.
APA, Harvard, Vancouver, ISO, and other styles
30

Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk (Drugs in Pregnancy and Lactation). 8th ed. Lippincott Williams & Wilkins, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Weiner, Carl, and Catalin Buhimschi. Drugs for Pregnant and Lactating Women. Churchill Livingstone, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Marshall, Tarnya, Rita Abdulkader, and Poonam Sharma. Antirheumatic drugs in pregnancy and lactation. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0097_update_003.

Full text
Abstract:
Antirheumatic drugs in pregnancy and lactation are increasingly a common clinical dilemma. With the shift towards early, aggressive control of autoimmune diseases and with the advent of newer therapeutic agents, there is a need to understand the effects of these medicines in pregnancy and lactation, on fertility in both men and women, and on the process of spermatogenesis, in order to understand the risk of teratogenesis. Although there are some limited data available for the use of antirheumatic drugs in pregnancy and lactation, much of our knowledge is derived from animal models and from limited clinical experience in human pregnancy. The balance of therapeutic benefits and risks of harm to mother and fetus should always be carefully considered: it may vary between individuals and should be assessed on a case by case basis. Because of these issues, pregnancy should always be discussed and planned in advance, in part to reduce disease activity prior to conception but also to minimize risk to the fetus. In this chapter we use the available evidence to discuss medicines which are commonly used in the treatment of rheumatological autoimmune diseases, and cover disease-modifying antirheumatic drugs (DMARDS) and biological agents.
APA, Harvard, Vancouver, ISO, and other styles
33

Drugs for Pregnant and Lactating Women. Elsevier - Health Sciences Division, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Lynch, Tara A., and J. Christopher Glantz. Seizure Medications Effects on Fetus, Neonate, and Lactation. Edited by Emma Ciafaloni, Cheryl Bushnell, and Loralei L. Thornburg. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190667351.003.0021.

Full text
Abstract:
Medication use in pregnancy requires a careful balance between the risks of fetal teratogenicity and the maternal benefits of disease treatment. For women with epilepsy, there are many antiepileptic medications available for use in pregnancy. Each varies in their safety profile, risk for fetal anomalies, and effectiveness of seizure control. In most scenarios, the benefits of maternal treatment outweigh the risk of fetal effects, especially in cases of refractory epilepsy or severe disease. Many of the newer anti-epileptic drugs appear to have less teratogenic risk than the older medications. The ideal AED is one that is effective from the woman, is least teratogenic, and used at the lowest possible dose. Overall, a detailed understanding of antiepileptic efficacy, the pharmacologic differences in pregnancy, and the potential adverse fetal effects are required for optimal treatment of pregnant patients with epilepsy.
APA, Harvard, Vancouver, ISO, and other styles
35

Marshall, Tarnya, and Rita Abdulkader. Anti-rheumatic drugs in pregnancy and lactation. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0097.

Full text
Abstract:
Anti-rheumatic drugs in pregnancy and lactation are increasingly a common clinical dilemma. With the shift towards early, aggressive control of autoimmune diseases and with the advent of newer therapeutic agents, there is a need to understand the effects of these medicines in pregnancy and lactation, on fertility in both men and women, and on the process of spermatogenesis, in order to understand the risk of teratogenesis. Although there are some limited data available for the use of anti-rheumatic drugs in pregnancy and lactation, much of our knowledge is derived from animal models and from limited clinical experience in human pregnancy. The balance of therapeutic benefits and risks of harm to mother and fetus should always be carefully considered: it may vary between individuals and should be assessed on a case by case basis. Because of these issues, pregnancy should always be discussed and planned in advance, in part to reduce disease activity prior to conception but also to minimize risk to the fetus. In this chapter we use the available evidence to discuss medicines which are commonly used in the treatment of rheumatological autoimmune diseases, and cover disease-modifying anti-rheumatic drugs (DMARDS) and biological agents.
APA, Harvard, Vancouver, ISO, and other styles
36

E, Rowe Hilary, ed. Medications & mothers' milk 2017: A manual of lactational pharmacology. Springer Publishing Company, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Buhimschi, Catalin, and Carl P. Weiner. Drugs for Pregnant and Lactating Women - CD-ROM PDA Software. Churchill Livingstone, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Briggs, Gerald G., R. K. Freeman, and S. J. Yaffe. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins,US, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Christof, Schaefer, ed. Drugs during pregnancy and lactation: Handbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs ... Amsterdam: Elsevier, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Ng, Bernardo, and Mauricio Tohen. Evidence-based treatment of mania. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198748625.003.0004.

Full text
Abstract:
Bipolar mania can be one of the most challenging psychiatric illnesses to treat, as it requires the clinician to make rapid and accurate decisions; have a reliable way of evaluating progress and treatment response; and possess keen psychotherapeutic skills. Therefore, the importance of staying updated on the clinical evidence of the various treatment options, which serves as the basis to individualize treatment on the day-to-day progress or deterioration of the manic patient. This chapter presents a review available on the evidence of different psychopharmacological agents including typical antipsychotics, lithium, antiepileptic drugs and atypical antipsychotics, and FDA-approved dosages. This review also includes these agents’ effects on fertility and recommendations about their use during pregnancy and lactation. Bipolar disorder continues to be a complex psychiatric condition, yet the progress in treatment options for the manic phase has evolved such that we have more options than ever before.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Lactation – Drug effects' for other source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography